![Göran Forsberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Göran Forsberg
Direktör/Styrelseledamot på
GUARD THERAPEUTICS INTERNATIONAL AB
Profil
Göran Forsberg is the founder of Trainparts Sweden AB, founded in 2014.
Current jobs include Independent Director at Guard Therapeutics International AB since 2019 and Director at Mesenkia Therapeutics AB starting in 2025.
Former jobs include Chief Executive Officer at Cantargia AB from 2014 to 2025, Non-Executive Director at Isogenica Ltd., Director at Active Security Trading AB, Director at Active Biotech Research AB, Director at Actinova AB, Head-Business Development & Investor Relation at the University of Adelaide, Head-Business Development & Investor Relation at Kabigen AB, and Chief Business Officer & VP-Investor Relations at Active Biotech AB from 2011 to 2014.
Aktiva positioner av Göran Forsberg
| Företag | Position | Start |
|---|---|---|
| GUARD THERAPEUTICS INTERNATIONAL AB | Direktör/Styrelseledamot | 2019-05-29 |
Tidigare kända positioner av Göran Forsberg
| Företag | Position | Slut |
|---|---|---|
| CANTARGIA AB | Verkställande Direktör | 2025-02-05 |
| ACTIVE BIOTECH AB | Investor Relations Kontakt | 2014-08-01 |
Trainparts Sweden AB
 Trainparts Sweden AB Metal FabricationProducer Manufacturing Engages in maintain, rebuild and remanufacture leaf springs, buffers and traction devices for railway vehicles | Grundare | - |
University of Adelaide
 University of Adelaide Other Consumer ServicesConsumer Services Functions as a College/University | Investor Relations Kontakt | - |
Kabigen AB | Investor Relations Kontakt | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
30
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
Active Biotech AB
 Active Biotech AB BiotechnologyHealth Technology Develops drugs for cancer, neurodegenerative and inflammatory diseases | Health Technology |
University of Adelaide
University of Adelaide Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Isogenica Ltd.
 Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services int he fields of new peptide, antibody and other polypeptide drug candidates | Commercial Services |
Kabigen AB | |
Cantargia AB
 Cantargia AB Pharmaceuticals: MajorHealth Technology Creates and develops antibody therapeutics for the treatment of leukemia | Health Technology |
Guard Therapeutics International AB
 Guard Therapeutics International AB Pharmaceuticals: MajorHealth Technology Develops medicine for oxidative stress and acute kidney damage | Health Technology |
Active Security Trading AB | |
Active Biotech Research AB
 Active Biotech Research AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Actinova AB | |
Trainparts Sweden AB
Trainparts Sweden AB Metal FabricationProducer Manufacturing Engages in maintain, rebuild and remanufacture leaf springs, buffers and traction devices for railway vehicles | Producer Manufacturing |
